Khiron Life Sciences Reports First Quarter 2022 Financial Results with Record Revenue in Medical Cannabis
- Tuesday, May 31, 2022, 7:00
- Finance
- Add a comment
The Corporation recorded revenues of $4.6 million in Q1 2022, a 65% increase from Q1 2021, and a 28% increase from Q4 2021 Record revenue in medical cannabis of over $2.6 million in Q1 2022, a 470% increase from the prior year and 32% increase from Q4 2021 Gross profit before fair value…
About the Author
adminasapcorp has written 41523 stories on this site.